Alpine Acquisition Corp.

CIK:0001853651|SEC Filings

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended		8 Months Ended	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2022
Statement of Comprehensive Income [Abstract]
Administrative fee - related party	$ 30,000	$ 10,000	$ 10,000	$ 90,000
General and administrative expenses	469,519	204,126	207,426	1,510,776
Total expenses	(499,519)	(214,126)	(217,426)	(1,600,776)
Other income (expense)
Interest income - Investments held in Trust Account	498,822	492	492	660,441
Offering costs allocated to warrants		(2,188,378)	(2,188,378)
Change in fair value of Note payable – related party	(130,702)			(74,039)
Change in fair value of derivative warrant liability	(315,075)	(1,571,425)	(1,571,425)	3,673,900
Total other income (expense)	53,045	(3,759,311)	(3,759,311)	4,260,302
Pre-tax income (loss)	(446,474)	(3,973,437)	(3,976,737)	2,659,526
Income tax	(76,848)			(76,848)
Net income (loss)	$ (523,322)	$ (3,973,437)	$ (3,976,737)	$ 2,582,678
Common stock subject to possible redemption - weighted average shares outstanding, basic and diluted (in Shares)	10,700,000	3,292,308	1,406,573	10,700,000
Common stock subject to possible redemption - Basic and diluted net income (loss) per share (in Dollars per share)	$ (0.04)	$ (0.67)	$ (0.97)	$ 0.19
Common stock not subject to possible redemption - weighted average shares outstanding, basic and diluted (in Shares)	2,850,000	2,675,000	2,675,000	2,850,000
Common stock not subject to possible redemption - Basic and diluted net income (loss) per share (in Dollars per share)	$ (0.04)	$ (0.67)	$ (0.97)	$ 0.19

Condensed Statements of Cash Flows (Unaudited) - USD ($)	8 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ (3,976,737)	$ 2,582,678
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Offering costs allocated to warrant liability	2,188,378
Change in fair value of derivative warrant liability	1,571,425	(3,673,900)
Change in fair value of Note payable – Related party		74,039
Interest earned on Trust assets	(492)	(660,441)
Changes in operating assets and liabilities:
Due to Sponsor	2,775
Prepaid expenses	(578,482)	(174,433)
Accrued expenses	80,141	433,361
Net cash used in operating activities	(715,767)	(1,418,696)
Cash flows from investing activities:
Cash deposited into Trust Account	(109,140,000)	(1,070,000)
Net cash used in investing activities	(109,140,000)	(1,070,000)
Cash flows from financing activities:
Sale of units in public offering, net	105,271,041
Sale of private placement warrants to Sponsor	5,152,500
Proceeds from issuance of common stock to Sponsor	25,000
Repayment of Note payable – Related party	(150,000)
Proceeds from Note payable – Related party	150,000	2,170,000
Net cash provided by financing activities	110,448,541	2,170,000
Net change in cash	592,774	(318,696)
Cash at beginning of period		367,110
Cash at end of period	592,774	48,414
Non-cash financing activities:
Deferred underwriters’ discounts and commissions	3,745,000
Remeasurement of common stock to redemption value		1,122,249
Common stock accretion to redemption value	$ 14,187,906

Condensed Balance Sheets - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current Assets
Cash	$ 48,414	$ 367,110
Due from Sponsor	25,000	25,000
Prepaid expenses and other current assets	718,263	354,559
Total Current Assets	791,677	746,669
Investments held in Trust Account	110,872,063	109,141,622
Prepaid expenses-non-current		189,271
Total Assets	111,663,740	110,077,562
Current Liabilities
Accounts payable and accrued expenses	607,941	174,579
Notes payable – related party	1,070,000
Note payable – related party at fair value (cost $1,100,000 and $0)	937,193
Total Current Liabilities	2,615,134	174,579
Deferred underwriting fee payable	3,745,000	3,745,000
Warrant liability	1,470,350	5,144,250
Total Liabilities	7,830,484	9,063,829
Commitments and contingencies (Note 6)
Common stock subject to possible redemption at redemption value (10,700,000 shares at $10.31 and $10.20)	110,499,095	109,140,000
Stockholders’ Deficit:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Common stock, $0.0001 par value; 50,000,000 shares authorized; 2,850,000 shares issued and outstanding (excludes 10,700,000 shares subject to possible redemption)	286	286
Additional paid-in capital
Accumulated deficit	(6,666,125)	(8,126,553)
Total Stockholders’ Deficit	(6,665,839)	(8,126,267)
Total Liabilities and Stockholders’ Deficit	$ 111,663,740	$ 110,077,562